Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Phase 2 Clinical Trial of GH001 in Postpartum Depression
GH Research Ireland Limited
Personality and Drug Use
Psychedelic Data Society
Trifecta Research Study
Johns Hopkins University
Safety and Pharmacokinetics of GH002 in Healthy Volunteers
GH Research Ireland Limited
Efficacy of Sublingual 5-MeO-DMT for Reducing Anxiety and Depression in MCI
Biomind Labs Inc.
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
Yale University
Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety
Biomind Labs Inc.
Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects
Beckley Psytech Limited
A Trial of GH001 in Patients With Treatment-resistant Depression
GH Research Ireland Limited
Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers
Usona Institute
Phase 2 Clinical Trial of GH001 in Bipolar II Disorder
GH Research Ireland Limited
Personality and Drug Use (PDU)
Quantified Citizen Technologies Inc.
Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects
GH Research Ireland Limited
Clinical Study of GH001 in Depression
GH Research Ireland Limited
Safety of GH001 in Healthy Volunteers
GH Research Ireland Limited
Pharmacokinetics of GH001 in Healthy Volunteers
GH Research Ireland Limited
How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
Read the trial details, eligibility criteria, and what participation involves.
Reach out to the study team using the contact information provided.
Complete the screening process to determine if you're eligible.